Association of plasma endothelial lipase levels on cognitive impairment

[1]  Rudolph E. Tanzi,et al.  Alzheimer’s Disease-Associated β-Amyloid Is Rapidly Seeded by Herpesviridae to Protect against Brain Infection , 2018, Neuron.

[2]  R. Cacabelos,et al.  Pharmacogenetics of Vascular Risk Factors in Alzheimer’s Disease , 2018, Journal of personalized medicine.

[3]  K. Anstey,et al.  Updating the Evidence on the Association between Serum Cholesterol and Risk of Late-Life Dementia: Review and Meta-Analysis , 2016, Journal of Alzheimer's disease : JAD.

[4]  K. Blennow,et al.  sTREM2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early‐stage Alzheimer's disease and associate with neuronal injury markers , 2016, EMBO molecular medicine.

[5]  M. Jensen,et al.  HDL-cholesterol and apolipoproteins in relation to dementia , 2016, Current opinion in lipidology.

[6]  Luis Carrasco,et al.  Different Brain Regions are Infected with Fungi in Alzheimer’s Disease , 2015, Scientific Reports.

[7]  S. Harris,et al.  Herpes Simplex Virus Type 1 and Other Pathogens are Key Causative Factors in Sporadic Alzheimer’s Disease , 2015, Journal of Alzheimer's disease : JAD.

[8]  Burkhard Becher,et al.  Immune attack: the role of inflammation in Alzheimer disease , 2015, Nature Reviews Neuroscience.

[9]  G. van Dijk,et al.  Integrative neurobiology of metabolic diseases, neuroinflammation, and neurodegeneration , 2015, Front. Neurosci..

[10]  B. Nordestgaard,et al.  Plasma levels of apolipoprotein E and risk of dementia in the general population , 2015, Annals of neurology.

[11]  J. Gallacher,et al.  Convergent genetic and expression data implicate immunity in Alzheimer's disease , 2014, Alzheimer's & Dementia.

[12]  G. Eslick,et al.  BACTERIAL INFECTION AND ALZHEIMER'S DISEASE: A META-ANALYSIS , 2014, Alzheimer's & Dementia.

[13]  J. Hardy,et al.  Genetics of Alzheimer’s Disease , 2014, Neurotherapeutics.

[14]  Guy D. Eslick,et al.  BACTERIAL INFECTION AND ALZHEIMER'S DISEASE: A META-ANALYSIS , 2014, Alzheimer's & Dementia.

[15]  R. Morishita,et al.  Systemic inflammation, blood-brain barrier vulnerability and cognitive/non-cognitive symptoms in Alzheimer disease: relevance to pathogenesis and therapy , 2014, Front. Aging Neurosci..

[16]  A. Hofman,et al.  The Impact of Partial and Complete Loss-of-Function Mutations in Endothelial Lipase on High-Density Lipoprotein Levels and Functionality in Humans , 2013, Circulation. Cardiovascular genetics.

[17]  D. Llewellyn,et al.  The neuropathological profile of mild cognitive impairment (MCI): a systematic review , 2012, Molecular Psychiatry.

[18]  T. Montine,et al.  Vascular diseases: One pathway toward new conceptual models of dementia , 2012, Alzheimer's & Dementia.

[19]  P. Sachdev,et al.  Plasma Apolipoprotein Levels Are Associated with Cognitive Status and Decline in a Community Cohort of Older Individuals , 2012, PloS one.

[20]  R. Veerhuis,et al.  Whether, when and how chronic inflammation increases the risk of developing late-onset Alzheimer's disease , 2012, Alzheimer's Research & Therapy.

[21]  C. Jonker,et al.  The role of lipoproteins and inflammation in cognitive decline: Do they interact? , 2012, Neurobiology of Aging.

[22]  S. Seneff,et al.  Association of alzheimer disease pathology with abnormal lipid metabolism: the hisayama study , 2012, Neurology.

[23]  G. Ricevuti,et al.  Alzheimer's disease, autoimmunity and inflammation. The good, the bad and the ugly. , 2011, Autoimmunity reviews.

[24]  T. Iwaki,et al.  Association of Alzheimer disease pathology with abnormal lipid metabolism , 2011, Neurology.

[25]  A. Sniderman,et al.  Reliability of low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B measurement. , 2011, Journal of clinical lipidology.

[26]  J. Morris,et al.  The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.

[27]  John Seibyl,et al.  Cerebral amyloid-β PET with florbetaben (18F) in patients with Alzheimer's disease and healthy controls: a multicentre phase 2 diagnostic study , 2011, The Lancet Neurology.

[28]  R. Mayeux,et al.  Association of higher levels of high-density lipoprotein cholesterol in elderly individuals and lower risk of late-onset Alzheimer disease. , 2010, Archives of neurology.

[29]  E. Walters,et al.  Dementia in Swedish Twins: Predicting Incident Cases , 2010, Behavior genetics.

[30]  K. Bales.  Brain lipid metabolism, apolipoprotein E and the pathophysiology of Alzheimer's disease , 2010, Neuropharmacology.

[31]  P. Foley.  Lipids in Alzheimer's disease: A century-old story. , 2010, Biochimica et biophysica acta.

[32]  K. Hirata,et al.  Pitavastatin decreases the expression of endothelial lipase both in vitro and in vivo. , 2010, Cardiovascular research.

[33]  Sang Won Seo,et al.  Seoul Neuropsychological Screening Battery-Dementia Version (SNSB-D): A Useful Tool for Assessing and Monitoring Cognitive Impairments in Dementia Patients , 2010, Journal of Korean medical science.

[34]  R. Shamburek,et al.  Seven direct methods for measuring HDL and LDL cholesterol compared with ultracentrifugation reference measurement procedures. , 2010, Clinical chemistry.

[35]  David Gimeno,et al.  Low HDL Cholesterol Is a Risk Factor for Deficit and Decline in Memory in Midlife: The Whitehall II Study , 2008, Arteriosclerosis, thrombosis, and vascular biology.

[36]  K. Tan,et al.  Type 2 diabetes mellitus and endothelial lipase. , 2008, Atherosclerosis.

[37]  M. Reilly,et al.  Endothelial Lipase Is Increased In Vivo by Inflammation in Humans , 2008, Circulation.

[38]  Guosong Qiu,et al.  Atorvastatin decreases lipoprotein lipase and endothelial lipase expression in human THP-1 macrophages Published, JLR Papers in Press, July 20, 2007. , 2007, Journal of Lipid Research.

[39]  K. Hirata,et al.  Endothelial lipase is increased by inflammation and promotes LDL uptake in macrophages. , 2007, Journal of atherosclerosis and thrombosis.

[40]  D. Rader,et al.  Endothelial lipase is associated with inflammation in humans Published, JLR Papers in Press, September 15, 2006. , 2006, Journal of Lipid Research.

[41]  N. Bresolin,et al.  Serum MCP-1 levels are increased in mild cognitive impairment and mild Alzheimer's disease , 2006, Neurobiology of Aging.

[42]  D. Rader,et al.  High-Density Lipoprotein Hydrolysis by Endothelial Lipase Activates PPAR&agr;: A Candidate Mechanism for High-Density Lipoprotein–Mediated Repression of Leukocyte Adhesion , 2006, Circulation research.

[43]  M. Reilly,et al.  Endothelial Lipase Concentrations Are Increased in Metabolic Syndrome and Associated with Coronary Atherosclerosis , 2005, PLoS medicine.

[44]  B. Egan,et al.  Platelet and White Blood Cell Counts Are Elevated in Patients With the Metabolic Syndrome , 2005, Journal of clinical hypertension.

[45]  K. Hirata,et al.  Endothelial Lipase Modulates Monocyte Adhesion to the Vessel Wall , 2004, Journal of Biological Chemistry.

[46]  K. Blennow,et al.  Intrathecal inflammation precedes development of Alzheimer’s disease , 2003, Journal of neurology, neurosurgery, and psychiatry.

[47]  L. Thal,et al.  Mild hypercholesterolemia is an early risk factor for the development of Alzheimer amyloid pathology , 2003, Neurology.

[48]  K. Hirata,et al.  Immunohistochemical localization of endothelial cell-derived lipase in atherosclerotic human coronary arteries. , 2003, Cardiovascular research.

[49]  D. Rader,et al.  Endothelial Cells Secrete Triglyceride Lipase and Phospholipase Activities in Response to Cytokines as a Result of Endothelial Lipase , 2003, Circulation research.

[50]  C. Ballantyne,et al.  Endothelial lipase is a major genetic determinant for high-density lipoprotein concentration, structure, and metabolism , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[51]  D. Rader,et al.  Inhibition of endothelial lipase causes increased HDL cholesterol levels in vivo. , 2003, The Journal of clinical investigation.

[52]  Sungshin Y. Choi,et al.  Endothelial lipase is a major determinant of HDL level. , 2003, The Journal of clinical investigation.

[53]  Jonathan C. Cohen.  Endothelial lipase: direct evidence for a role in HDL metabolism. , 2003, The Journal of clinical investigation.

[54]  D. Rader,et al.  Identification of Genetic Variants in Endothelial Lipase in Persons With Elevated High-Density Lipoprotein Cholesterol , 2002, Circulation.

[55]  R. Schmidt,et al.  Early inflammation and dementia: A 25‐year follow‐up of the Honolulu‐Asia aging study , 2002, Annals of neurology.

[56]  L. Launer,et al.  Cholesterol and neuropathologic markers of AD , 2001, Neurology.

[57]  L. Launer,et al.  Cholesterol and neuropathologic markers of AD: A population-based autopsy study , 2001 .

[58]  Qun Zhou,et al.  The role of endothelial lipase in lipid metabolism, inflammation, and cancer. , 2018, Histology and histopathology.

[59]  D. Werring,et al.  18F-AV-1451 PET Imaging in Three Patients with Probable Cerebral Amyloid Angiopathy. , 2017, Journal of Alzheimer's disease : JAD.

[60]  O. Franco,et al.  Exome-sequencing in a large population-based study reveals a rare Asn396Ser variant in the LIPG gene associated with depressive symptoms , 2017, Molecular Psychiatry.

[61]  Luis Carrasco,et al.  Fungal infection in patients with Alzheimer's disease. , 2014, Journal of Alzheimer's disease : JAD.

[62]  Abdulaziz Al-Rasheed.  Elevation of white blood cells and platelet counts in patients having chronic periodontitis. , 2012, The Saudi dental journal.

[63]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[64]  J. Adair,et al.  Cholesterol and neuropathologic markers of AD , 2001, Neurology.

[65]  E. Tangalos,et al.  Mild Cognitive Impairment Clinical Characterization and Outcome , 1999 .